Kondo T - Search Results

1

Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy.

Shimada S, Yamada T, Minamoto A, Matsukawa M, Yabe I, Tada H, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Shimada S, et al. Among authors: kondo t. J Hum Genet. 2025 Jan;70(1):33-40. doi: 10.1038/s10038-024-01294-x. Epub 2024 Sep 17. J Hum Genet. 2025. PMID: 39289525

2

Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.

Minamoto A, Yamada T, Shimada S, Kinoshita I, Aoki Y, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Minamoto A, et al. Among authors: kondo t. J Hum Genet. 2022 Oct;67(10):557-563. doi: 10.1038/s10038-022-01028-x. Epub 2022 Mar 23. J Hum Genet. 2022. PMID: 35322199

3

Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.

Yamamoto Y, Kanai M, Kou T, Sugiyama A, Nakamura E, Miyake H, Yamada T, Nishigaki M, Kondo T, Murakami H, Torishima M, Matsumoto S, Kosugi S, Muto M. Yamamoto Y, et al. Among authors: kondo t. J Hum Genet. 2020 Jan;65(2):125-132. doi: 10.1038/s10038-019-0681-6. Epub 2019 Oct 18. J Hum Genet. 2020. PMID: 31628423 Free PMC article.

4

Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.

Kondo T, Matsubara J, Quy PN, Fukuyama K, Nomura M, Funakoshi T, Doi K, Sakamori Y, Yoshioka M, Yokoyama A, Tamaoki M, Kou T, Hirohashi K, Yamada A, Yamamoto Y, Minamiguchi S, Nishigaki M, Yamada T, Kanai M, Matsumoto S, Muto M. Kondo T, et al. Cancer Sci. 2021 Jan;112(1):296-304. doi: 10.1111/cas.14674. Epub 2020 Nov 21. Cancer Sci. 2021. PMID: 33007138 Free PMC article.

5

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling.

Kondo T, Yamamoto Y, Fukuyama K, Kanai M, Yamada A, Matsubara J, Quy PN, Yoshioka M, Yamada T, Minamiguchi S, Matsumoto S, Kosugi S, Muto M. Kondo T, et al. Int J Clin Oncol. 2022 Aug;27(8):1256-1263. doi: 10.1007/s10147-022-02176-y. Epub 2022 May 14. Int J Clin Oncol. 2022. PMID: 35567649

6

[From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].

Muto M, Kondo T, Yoshioka M, Fukuyama K, Suga J, Sato M, Masuda F, Ashida K, Mukai K, Matsumoto S, Kanai M. Muto M, et al. Among authors: kondo t. Gan To Kagaku Ryoho. 2021 Jul;48(7):866-872. Gan To Kagaku Ryoho. 2021. PMID: 34267018 Japanese.

7

First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

Matsubara J, Mukai K, Kondo T, Yoshioka M, Kage H, Oda K, Kudo R, Ikeda S, Ebi H, Muro K, Hayashi R, Tokudome N, Yamamoto N, Muto M. Matsubara J, et al. Among authors: kondo t. JAMA Netw Open. 2023 Jul 3;6(7):e2323336. doi: 10.1001/jamanetworkopen.2023.23336. JAMA Netw Open. 2023. PMID: 37459099 Free PMC article.

8

[Precision Medicine Provided by National Health Insurance].

Muto M, Kondo T, Matsubara J, Kanai M, Matsumoto S, Ashida K, Suga J, Mukai K. Muto M, et al. Among authors: kondo t. Gan To Kagaku Ryoho. 2020 Aug;47(8):1158-1163. Gan To Kagaku Ryoho. 2020. PMID: 32829347 Japanese.

9

BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer.

Kondo T, Kanai M, Matsubara J, Quy PN, Fukuyama K, Yamamoto Y, Yamada T, Nishigaki M, Minamiguchi S, Takeda M, Nishio K, Matsumoto S, Muto M. Kondo T, et al. Pancreas. 2020 Nov/Dec;49(10):e101-e103. doi: 10.1097/MPA.0000000000001672. Pancreas. 2020. PMID: 33017331 Free PMC article. No abstract available.

10

Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Yamamoto Y, Fukuyama K, Kanai M, Kondo T, Yoshioka M, Kou T, Quy PN, Kimura-Tsuchiya R, Yamada T, Matsumoto S, Kosugi S, Muto M. Yamamoto Y, et al. Among authors: kondo t. Int J Clin Oncol. 2022 Oct;27(10):1554-1561. doi: 10.1007/s10147-022-02220-x. Epub 2022 Jul 23. Int J Clin Oncol. 2022. PMID: 35870019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,784 results

Search Page

Filters